496 related articles for article (PubMed ID: 15649697)
21. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
22. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
23. ApoE isoform affects LTP in human targeted replacement mice.
Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Ye GL; Sotak M; Sullivan PM; Pasternak JF; LaDu MJ
Neuroreport; 2004 Dec; 15(17):2655-8. PubMed ID: 15570172
[TBL] [Abstract][Full Text] [Related]
24. Isoform-specific proteolysis of apolipoprotein-E in the brain.
Elliott DA; Tsoi K; Holinkova S; Chan SL; Kim WS; Halliday GM; Rye KA; Garner B
Neurobiol Aging; 2011 Feb; 32(2):257-71. PubMed ID: 19278755
[TBL] [Abstract][Full Text] [Related]
25. Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta.
Morikawa M; Fryer JD; Sullivan PM; Christopher EA; Wahrle SE; DeMattos RB; O'Dell MA; Fagan AM; Lashuel HA; Walz T; Asai K; Holtzman DM
Neurobiol Dis; 2005; 19(1-2):66-76. PubMed ID: 15837562
[TBL] [Abstract][Full Text] [Related]
26. Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40).
Aleshkov SB; Li X; Lavrentiadou SN; Zannis VI
Biochemistry; 1999 Jul; 38(28):8918-25. PubMed ID: 10413465
[TBL] [Abstract][Full Text] [Related]
27. Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice.
Osorio C; Sullivan PM; He DN; Mace BE; Ervin JF; Strittmatter WJ; Alzate O
Neurobiol Aging; 2007 Dec; 28(12):1853-62. PubMed ID: 17050040
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E and Alzheimer disease.
Huang Y
Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation.
Huebbe P; Schaffer S; Jofre-Monseny L; Boesch-Saadatmandi C; Minihane AM; Müller WE; Eckert GP; Rimbach G
Mol Nutr Food Res; 2007 Dec; 51(12):1510-7. PubMed ID: 18030662
[TBL] [Abstract][Full Text] [Related]
30. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice.
Sheng H; Laskowitz DT; Bennett E; Schmechel DE; Bart RD; Saunders AM; Pearlstein RD; Roses AD; Warner DS
J Cereb Blood Flow Metab; 1998 Apr; 18(4):361-6. PubMed ID: 9538900
[TBL] [Abstract][Full Text] [Related]
32. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
[TBL] [Abstract][Full Text] [Related]
33. Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid.
Yamauchi K; Tozuka M; Nakabayashi T; Sugano M; Hidaka H; Kondo Y; Katsuyama T
J Neurosci Res; 1999 Oct; 58(2):301-7. PubMed ID: 10502286
[TBL] [Abstract][Full Text] [Related]
34. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
35. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology.
Wang C; Wilson WA; Moore SD; Mace BE; Maeda N; Schmechel DE; Sullivan PM
Neurobiol Dis; 2005 Mar; 18(2):390-8. PubMed ID: 15686968
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E-genotype dependent hippocampal and cortical responses to traumatic brain injury.
Crawford F; Wood M; Ferguson S; Mathura V; Gupta P; Humphrey J; Mouzon B; Laporte V; Margenthaler E; O'Steen B; Hayes R; Roses A; Mullan M
Neuroscience; 2009 Apr; 159(4):1349-62. PubMed ID: 19409232
[TBL] [Abstract][Full Text] [Related]
37. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation.
Nilsson LN; Arendash GW; Leighty RE; Costa DA; Low MA; Garcia MF; Cracciolo JR; Rojiani A; Wu X; Bales KR; Paul SM; Potter H
Neurobiol Aging; 2004 Oct; 25(9):1153-67. PubMed ID: 15312961
[TBL] [Abstract][Full Text] [Related]
38. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.
Wood SJ; Chan W; Wetzel R
Biochemistry; 1996 Sep; 35(38):12623-8. PubMed ID: 8823200
[TBL] [Abstract][Full Text] [Related]
39. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.
Cole GM; Ard MD
Microsc Res Tech; 2000 Aug; 50(4):316-24. PubMed ID: 10936886
[TBL] [Abstract][Full Text] [Related]
40. Isoform-specific effects of apolipoprotein E on cognitive performance in targeted-replacement mice overexpressing human APP.
Kornecook TJ; McKinney AP; Ferguson MT; Dodart JC
Genes Brain Behav; 2010 Mar; 9(2):182-92. PubMed ID: 20002203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
